Deferred Tax Assets, Valuation Allowance of Apyx Medical Corp from 31 Dec 2015 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Apyx Medical Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2024.
  • Apyx Medical Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $20,697,000, a 26% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Apyx Medical Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $20,697,000 +$4,254,000 +26% 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $16,443,000 +$4,375,000 +36% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $12,068,000 +$5,100,000 +73% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $6,968,000 +$3,131,000 +82% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q4 2020 $3,837,000 -$2,635,000 -41% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 $6,472,000 +$4,730,000 +272% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $1,742,000 -$7,014,000 -80% 31 Dec 2018 10-K 31 Mar 2020 2019 FY
Q4 2017 $8,756,000 -$1,429,000 -14% 31 Dec 2017 10-K 31 Mar 2020 2019 FY
Q4 2016 $10,185,000 +$2,781,000 +38% 31 Dec 2016 10-K 14 Mar 2019 2018 FY
Q4 2015 $7,404,000 31 Dec 2015 10-K 10 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.